Community-Acquired Pneumonia: Treatment Options For Common Pathogens

Community-Acquired Pneumonia: Treatment Options For Common Pathogens is organized by Power-Pak C.E. - Continuing Education for Pharmacists & Pharmacy Technicians.

Published Date: June 13, 2025
Expired Date: June 13, 2028

Description:
To identify key organisms causing community-acquired pneumonia, assess risk factors for drug-resistant pathogens, and apply evidence-based treatment strategies, including new therapeutic options, in patient care.

Educational Objectives:
Upon completion of this activity, the participant should be able to:

• Identify the most common pathogens that cause community-acquired pneumonia (CAP)
• List the risk factors for CAP caused by drug-resistant Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus, and Pseudomonas aeruginosa
• Describe new therapeutic options for the treatment of community-acquired bacterial pneumonia
• Practice gathering data on immunizations and laboratory tests needed by the pharmacist to design an appropriate treatment plan for patients with CAP using current evidence-based guidelines.